Precigen (PGEN) Change in Accured Expenses (2016 - 2025)

Precigen (PGEN) has disclosed Change in Accured Expenses for 13 consecutive years, with $5.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Accured Expenses rose 215.77% to $5.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.5 million, a 17.62% increase, with the full-year FY2024 number at -$1.8 million, down 134.95% from a year prior.
  • Change in Accured Expenses was $5.0 million for Q3 2025 at Precigen, up from $385000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $5.0 million in Q3 2025 to a low of -$3.2 million in Q4 2024.
  • A 5-year average of $623684.2 and a median of $385000.0 in 2025 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: plummeted 194100.0% in 2022, then skyrocketed 3819.51% in 2023.
  • Precigen's Change in Accured Expenses stood at $1.9 million in 2021, then plummeted by 97.79% to $41000.0 in 2022, then surged by 3819.51% to $1.6 million in 2023, then crashed by 296.95% to -$3.2 million in 2024, then surged by 256.94% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Change in Accured Expenses are $5.0 million (Q3 2025), $385000.0 (Q2 2025), and $1.3 million (Q1 2025).